Nadav Kidron
President and CEO at Oramed Pharmaceuticals Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Oramed Pharmaceuticals Inc., 3 years.
Oramed Pharmaceuticals Inc.
Director · President and CEO
Alpha Tau Medical Ltd.
Director
Lifeward Ltd.
Director
Chief executive roles
Oramed Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Oramed Pharmaceuticals Inc. | Shares withheld for tax | −44,818 | $3.31 | $148,348 |
| Mar 25, 2026 | Lifeward Ltd. | Grant or award | +7,657 | — | — |
| Mar 17, 2026 | Oramed Pharmaceuticals Inc. | Grant or award | +167,005 | — | — |
| Mar 12, 2026 | Oramed Pharmaceuticals Inc. | Gift | −100,000 | — | — |
| Jan 22, 2026 | Oramed Pharmaceuticals Inc. | Option exercise | +109,000 | — | — |
| Dec 31, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +232,640 | — | — |
| Dec 31, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +327,000 | — | — |
| Feb 11, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +141,000 | — | — |
| Feb 11, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +186,000 | — | — |
| Feb 11, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +100,000 | — | — |
| Jan 2, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +433,500 | — | — |
| Nov 7, 2024 | Oramed Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| Jan 4, 2024 | Oramed Pharmaceuticals Inc. | Grant or award | +329,000 | — | — |
| May 26, 2023 | Oramed Pharmaceuticals Inc. | Grant or award | +120,000 | — | — |
| Apr 17, 2023 | Oramed Pharmaceuticals Inc. | Grant or award | +279,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.